Log in to search using one of your social media accounts:

 

Correspondence 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia

Motoi Suzuki and colleagues1 found that 23-valent pneumococcal polysaccharide vaccine (PPV23) showed low to moderate effectiveness against vaccine serotype pneumococcal pneumonia in Japanese people aged 65 years or older treated at four community-based hospitals from September, 2011, to August, 2014. As the authors wrote, 7-valent pneumococcal conjugate vaccine (PCV7) became commercially available for Japanese children in February, 2010, and it was incorporated into the routine immunisation schedule for children in April, 2013.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research

Related Links:

Publication date: Available online 9 December 2017 Source:Infectious Disease Clinics of North America Author(s): David F. Butler, Angela L. MyersTeaser Haemophilus influenzae remains a common cause of illness in children throughout the world. Before the introduction of vaccination, H influenzae type b (Hib) disease was the leading cause of bacterial meningitis in young children and a frequent cause of pneumonia, epiglottitis, and septic arthritis. Clinicians should remain diligent in counseling parents on the dangers of Hib and provide vaccination starting at 2 months of age. The epidemiology of invasive H influenzae...
Source: Infectious Disease Clinics of North America - Category: Infectious Diseases Source Type: research
CONCLUSION Taken together, our results suggest that KRG reduces the time required for immunization with the Δpep27 vaccine by enhancing its efficacy.
Source: Journal of Ginseng Research - Category: Complementary Medicine Source Type: research
Haemophilus influenzae remains a common cause of illness in children throughout the world. Before the introduction of vaccination, H influenzae type b (Hib) disease was the leading cause of bacterial meningitis in young children and a frequent cause of pneumonia, epiglottitis, and septic arthritis. Clinicians should remain diligent in counseling parents on the dangers of Hib and provide vaccination starting at 2  months of age. The epidemiology of invasive H influenzae disease is shifting. It is imperative that clinicians recognize the changing epidemiology and antibiotic resistance patterns for H influenzae to optimi...
Source: Infectious Diseases Clinics of North America - Category: Infectious Diseases Authors: Source Type: research
Conclusions: PCV introduction in infants impacts the microbial etiology of adult CAP.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory Infections Source Type: research
Conclusions: There is a high prevalence of macrolide and tetracycline resistance S. pneumonia with a low PCV7 coverage. The serogroup 19 MDR CC320/271 clone warrants close monitoring to evaluate its effect after the switch to expanded conjugate vaccines.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory Infections Source Type: research
Conclusions: After PCV7 vaccine was implemented, a decrease of BPP caused by these serotypes was noted. Despite the implementation of PCV13 in children in 2010, PCV13-7 serotypes increased in 3 periods of study, being statistically significant in adults ≥65 y.o and adults with comorbidities. Thus, PCV13 vaccination should include not only children but also adults with comorbidities.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory Infections Source Type: research
Aim was to study efficiency of specific prevention of pneumococcal infection at patients from the risk groups in Krasnoyarsk region.12 080 patients with chronic lung diseases, chronic heart failure and diabetes mellitus were examined. The special questionnaire which included anamnesis assessment within the year previous bacterinations and anamnesis of basic disease within a year after bacterination was developed for assessment of clinical performance of bacterination.Immunization against pneumococcal infection was carried out to the following categories of patients: 41.08% with chronic heart failure, 28.44% suffering from ...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory Infections Source Type: research
Conclusion: 23PPV vaccination of young people several months before being placed in organized communities substantially reduced CAP morbidity and the relative occurrence of moderate and severe CAP forms.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory Infections Source Type: research
Conclusion: PPSV23 was effective and immunization should be scheduled at the early period for the patients with lung comorbidities including in immunosuppressive state.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory Infections Source Type: research
Background: The study aimed to investigate whether the clinical presentations and outcomes of pneumococcal pneumonia in virologically suppressed HIV-infected patients on ART with a CD4+ T cell count>350 cells/mm3 are comparable to those seen in non-HIV-infected patients, using a case-control designMethods: A case-control study was carried out in Hospital Clinic, Barcelona, Spain (2001-2016). Controls were matched by age (±10 years), gender, co-morbidities and pneumonia diagnosis in the same calendar period. Clinical presentation and outcomes of pneumococcal pneumonia in HIV-infected patients and non-HIV-infected ...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory Infections Source Type: research
More News: Children | Hospitals | Infectious Diseases | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Vaccines